Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / articles / why is prostate cancer focused lantheus stock tradin mwn benzinga

PNT - Why is Prostate Cancer Focused Lantheus Stock Trading Lower Today? | Benzinga

POINT Biopharma Global Inc.

Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic castration-resistant prostate cancer after progression on an androgen receptor pathway inhibitor (ARPI).

177Lu-PNT2002 is a prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT).

The SPLASH trial ...

Full story available on Benzinga.com
Stock Information
Company Name: POINT Biopharma Global Inc.
Stock Symbol: PNT
Market: NASDAQ
Menu
PNT PNT Quote PNT Short PNT News PNT Articles PNT Message Board
Get PNT Alerts

News, Short Squeeze, Breakout and More Instantly...